Effect of Gluten Free Diet in Patients With Burning Mouth Syndrome
Effetto Della Dieta Priva di Glutine in Soggetti Con BMS
1 other identifier
interventional
40
1 country
1
Brief Summary
Gluten free diet (GFD) is now being tested in patients affected by schizophrenia, autism and multiple sclerosis, making GFD a possible therapeutic weapon not only for celiac disease or gluten sensitivity. In this protocol we investigate the effect of GFD in patients affected by burning mouth syndrome (BMS), a disease of unknown origin characterized by oral and especially tongue burning sensation, deeply decreasing the quality of life of patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 29, 2013
CompletedFirst Posted
Study publicly available on registry
June 3, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2014
CompletedJune 3, 2013
May 1, 2013
Same day
May 29, 2013
May 31, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
oral pain
oral pain will be evaluated by means of visual analogue scales
28 days
Secondary Outcomes (1)
Quality of Life
28 days
Study Arms (2)
Gluten free diet
EXPERIMENTALBMS patients following a GFD
Normal Diet
SHAM COMPARATORPatients with BMS maintaing a normal diet
Interventions
Eligibility Criteria
You may qualify if:
- Primary BMS
You may not qualify if:
- Celiac Disease
- Psychiatric Disorders
- intestinal autoimmune diseases
- Ongoing cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondazione IRCCS Ca' Granda
Milan, Italy, 20122, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Luca Elli, MD
Fondazione IRCCS Cà Granda
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Scientific Director
Study Record Dates
First Submitted
May 29, 2013
First Posted
June 3, 2013
Study Start
May 1, 2013
Primary Completion
May 1, 2013
Study Completion
March 1, 2014
Last Updated
June 3, 2013
Record last verified: 2013-05